Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer.

Indian journal of medical sciences

Volumn 52, Issue 6, 1998, Pages 244-247

  Vaidya, S M ^a   Kamlakar, P L ^a   Kamble, S M ^a  

^a GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; MOLYBDENUM; RIBOFLAVIN; TAMOXIFEN; XANTHINE OXIDASE;

ARTICLE; BLOOD; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MIDDLE AGED; POSTMENOPAUSE;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; MOLYBDENUM; POSTMENOPAUSE; RIBOFLAVIN; TAMOXIFEN; XANTHINE OXIDASE;

EID: 0032082340     PISSN: 00195359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)